FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * ARMSTRONG JR. JOHN L. 2. Issuer Name and Ticker or Trading Symbol CorMedix Inc. [ CRMD ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Exec VP of Tech Operations
(Last)         (First)         (Middle)
C/O CORMEDIX INC., 400 CONNELL DRIVE, SUITE 5000
3. Date of Earliest Transaction (MM/DD/YYYY)
5/11/2020
(Street)
BERKELEY HEIGHTS, NJ 07922
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                 69378.0000  D 
 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy Common Stock)  $5.6300  5/11/2020    A     37500.0000       (1) 5/11/2030  Common Stock  37500.0000  $5.6300  37500.0000  D 
 
Stock Option (Right to Buy Common Stock)  $4.0800  5/11/2020    A     37500.0000       (1) 5/11/2030  Common Stock  37500.0000  $4.0800  37500.0000  D 
 
Stock Option (Right to Buy Common Stock)  $5.6300                   (2) 2/25/2030  Common Stock  24764.0000    24764.0000  D 
 
Stock Option (Right to Buy Common Stock)  $8.3000                   (3) 1/10/2029  Common Stock  7830.0000    7830.0000  D 
 
Stock Option (Right to Buy Common Stock)  $10.9000                   (4) 3/1/2027  Common Stock  13400.0000    13400.0000  D 
 
Stock Option (Right to Buy Common Stock)  $7.6000                   (5) 11/14/2024  Common Stock  2000.0000    2000.0000  D 
 
Stock Option (Right to Buy Common Stock)  $16.2500                   (6) 7/28/2025  Common Stock  3000.0000    3000.0000  D 
 
Stock Option (Right to Buy Common Stock)  $12.5500                   (7) 3/8/2026  Common Stock  40000.0000    40000.0000  D 
 

Explanation of Responses:
(1)  These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
(2)  These options were granted on 02/25/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.
(3)  These options were granted on 1/10/2019. These options vest, subject to continued employment, as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones. These options include options to purchase an aggregate of 1,575 shares that are subject to vesting 50% on January 10, 2021 and 50% on January 10, 2022.
(4)  The option vests based on certain performance milestones. The option will be forfeited if such milestones are not met by certain dates. These options include options to purchase 6,800 shares that are subject to the achievement of certain milestones.
(5)  These options vested upon the achievement of certain milestones, subject to continued employment.
(6)  One third of these options vested upon the achievement of a certain milestone and one third vested on each of December 31, 2015 and July 28, 2015.
(7)  15,000 of these options vested monthly over four years, beginning on March 9, 2016, 20,000 vest upon the achievement of a certain milestone, subject to continued employment, and the rest vested upon the achievement of certain milestones.

Remarks:
The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
ARMSTRONG JR. JOHN L.
C/O CORMEDIX INC.
400 CONNELL DRIVE, SUITE 5000
BERKELEY HEIGHTS, NJ 07922


Exec VP of Tech Operations

Signatures
/s/ John L. Armstrong Jr. 5/13/2020
**Signature of Reporting Person Date
CorMedix (AMEX:CRMD)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more CorMedix Charts.
CorMedix (AMEX:CRMD)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more CorMedix Charts.